Cargando…
PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430098/ http://dx.doi.org/10.1097/01.HS9.0000974364.56956.b1 |
| _version_ | 1785090873547030528 |
|---|---|
| author | Zeidan, Amer M Fathi, Amir Issa, Ghayas Erba, Harry Mackey, Julie Ahsan Corum, Daniel Tomkinson, Blake Kozlek, Tom Leoni, Mollie Wang, Eunice |
| author_facet | Zeidan, Amer M Fathi, Amir Issa, Ghayas Erba, Harry Mackey, Julie Ahsan Corum, Daniel Tomkinson, Blake Kozlek, Tom Leoni, Mollie Wang, Eunice |
| author_sort | Zeidan, Amer M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104300982023-08-17 PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA Zeidan, Amer M Fathi, Amir Issa, Ghayas Erba, Harry Mackey, Julie Ahsan Corum, Daniel Tomkinson, Blake Kozlek, Tom Leoni, Mollie Wang, Eunice Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430098/ http://dx.doi.org/10.1097/01.HS9.0000974364.56956.b1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zeidan, Amer M Fathi, Amir Issa, Ghayas Erba, Harry Mackey, Julie Ahsan Corum, Daniel Tomkinson, Blake Kozlek, Tom Leoni, Mollie Wang, Eunice PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title | PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_full | PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_fullStr | PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_full_unstemmed | PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_short | PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_sort | pb1885: phase 1 study of ziftomenib in combination with venetoclax, venetoclax/azacitidine, or standard induction (7 + 3) chemotherapy in patients with acute myeloid leukemia |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430098/ http://dx.doi.org/10.1097/01.HS9.0000974364.56956.b1 |
| work_keys_str_mv | AT zeidanamerm pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT fathiamir pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT issaghayas pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT erbaharry pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT mackeyjulieahsan pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT corumdaniel pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT tomkinsonblake pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT kozlektom pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT leonimollie pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia AT wangeunice pb1885phase1studyofziftomenibincombinationwithvenetoclaxvenetoclaxazacitidineorstandardinduction73chemotherapyinpatientswithacutemyeloidleukemia |